Home About Us Events Advanced Therapies London

Advanced Therapies London

March 19-20, 2024


Advanced Therapies Congress EU

FUJIFILM Diosynth is delighted to be a platinum sponsor at Advanced Therapies, March 19-20, 2024 at ExCel, London. Schedule a meeting via meeting app or stop by booth #10 meet with our team to learn more about FUJIFILM Diosynth Biotechnologies’ capabilities and how we can help you advance and deliver tomorrow’s medicines.

Keynote Presentation – Wednesday, March 20th @ 10:10 am

Michael Baker, Senior Director Viral Gene Therapy, FUJIFILM Diosynth Biotechnologies, UK will speak on The future of Advanced Therapies, a CDMO perspective.

  • Currently, the majority of launched gene therapies have been in the rare disease space with small patient populations and relatively low doses. These processes have largely relied on transient production of the viral vectors at volumes below 2000L. Whilst this approach has enabled companies to get products to market, the resultant cost is prohibitively high when the curative potential of the therapy is not always met. This becomes even more problematic for mass market, high dose indications. Whilst developers are working to reduce dose requirements and improve efficacy, efforts are required throughout the industry to tackle this multifaceted problem. FUJIFILM Diosynth Biotechnologies (FDB) are working to develop a number of enabling technologies for the scale up and mass production of viral vectors. This talk will discuss how innovation within Fujifilm is being used to alleviate obstacles currently facing ATMP manufacturing from pre-clinical to commercial and beyond.

Click here for the complete agenda and registration